HR
TAK icon

Howe & Rusling’s Takeda Pharmaceutical TAK Stock Holding History

Howe & Rusling’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100
Closed -$1K – 945
2022
Q3 		$1K Hold
100
– – ﹤0.01% 1010
2022
Q2 		$1K Hold
100
– – ﹤0.01% 1001
2022
Q1 		$1K Hold
100
– – ﹤0.01% 962
2021
Q4 		$1K Hold
100
– – ﹤0.01% 958
2021
Q3 		$2K Hold
100
– – ﹤0.01% 881
2021
Q2 		$2K Hold
100
– – ﹤0.01% 836
2021
Q1 		$2K Buy
+100
New +$1.8K ﹤0.01% 847

Other funds holding TAK

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Howe & Rusling's TAK Position: Q4 2022 in Review

Howe & Rusling sold out of Takeda Pharmaceutical (TAK) in Q4 2022, closing a stake of 100 shares — an estimated $1K sold.

Howe & Rusling first reported a position in TAK in Q1 2021 and held it in 7 quarters. The position peaked at $2K in Q3 2021. 281 funds tracked by Wall St. Rank hold TAK as of Q4 2022.

  • Howe & Rusling reported no remaining Takeda Pharmaceutical position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 100 Takeda Pharmaceutical shares in Q4 2022, an estimated $1K.
  • Howe & Rusling first reported a position in Takeda Pharmaceutical in Q1 2021 and held it in 7 quarters.
  • Howe & Rusling's Takeda Pharmaceutical position peaked at $2K in Q3 2021.
  • 281 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.